Robert Stratta to Cytomegalovirus Infections
This is a "connection" page, showing publications Robert Stratta has written about Cytomegalovirus Infections.
Connection Strength
0.810
-
Stratta RJ, Pietrangeli C, Baillie GM. Defining the risks for cytomegalovirus infection and disease after solid organ transplantation. Pharmacotherapy. 2010 Feb; 30(2):144-57.
Score: 0.366
-
Somerville T, Hurst G, Alloway R, Gaber A, Shokouh-Amiri MH, Stratta R. Superior efficacy of oral ganciclovir over oral acyclovir for cytomegalovirus prophylaxis in kidney-pancreas and pancreas alone recipients. Transplant Proc. 1998 Jun; 30(4):1546-8.
Score: 0.163
-
Stratta RJ, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Doares W, Kaczmorski S, Farney AC. Depleting antibody induction in simultaneous pancreas-kidney transplantation: a prospective single-center comparison of alemtuzumab versus rabbit anti-thymocyte globulin. Expert Opin Biol Ther. 2014 Dec; 14(12):1723-30.
Score: 0.125
-
Stratta R, Shaefer M, Markin R, Bradshaw K, Donovan J, Wood R, Langnas A, Reed E, Woods G, Zetterman R, et al. Ganciclovir therapy for viral disease in liver transplant recipients. Transplant Proc. 1991 Jun; 23(3):1968.
Score: 0.100
-
Stratta RJ, Rohr MS, Adams PL, Sundberg AK, Hartmann EL, Armstrong G, Anderson TK, Farney AC, Roskopf JA, Hairston G, Kiger DF, Nagaraj SK, Iskandar SS, Assimos DG. Kidney and pancreas transplantation at Wake Forest University Baptist Medical Center. Clin Transpl. 2003; 229-45.
Score: 0.056